|
2011-04-30 |
Change in Manufacture Process of Heberbiovac HB vaccine. |
CIGB |
Registered |
|
2011-04-27 |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
CIGB |
Registered |
|
2010-12-20 |
CIGB500 in healthy volunteers |
CIGB |
Registered |
|
2010-12-20 |
THERESA-2 Study |
CIGB |
Registered |
|
2008-10-07 |
THERESA |
CIGB |
Registered |
|
2009-02-27 |
Safety and immunogenicity of commercial Hepatitis B vaccines. |
CIGB |
Registered |
|
2010-12-20 |
Dynamic-I |
CIGB |
Registered |
|
2008-10-07 |
FarmaPEG-I |
CIGB |
Registered |
|
2010-12-20 |
Dermosep-I |
CIGB |
Registered |
|
2010-12-20 |
EPANEM-III |
CIGB |
Registered |
|
2010-12-20 |
AntiCEA M3-I |
CIGB |
Registered |
|
2010-06-11 |
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
CIGB |
Registered |
|
2010-12-24 |
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
CIGB |
Registered |
|
2010-12-24 |
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
CIGB |
Registered |
|
2009-12-24 |
InCroMiel I |
CIGB |
Registered |
|
2010-12-24 |
InCCNM -I |
CIGB |
Registered |
|
2009-02-26 |
CITOPROT-III |
CIGB |
Registered |
|
2010-12-24 |
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
CIGB |
Registered |
|
2010-12-24 |
CIGB-128 administration to patients with surgically-treated keloids. |
CIGB |
Registered |
|
2010-12-27 |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
CIGB |
Registered |
